Deletion of Mfsd2b impairs thrombotic functions of platelets - Chandrakanthan, Madhuvanthi; Nguyen, Toan Quoc; Hasan, Zafrul; Muralidharan, Sneha; Vu, Thiet Minh; Li, Aaron Wei Liang; Le, Uyen Thanh Nha; Thi Thuy Ha, Hoa; Baik, Sang-Ha; Tan, Sock Hwee; Foo, Juat Chin; Wenk, Markus R.; et al. (Nature communications, 2021)
Keywords: 13/31; 631/45/287/1196; 631/80/2023; 64/60; 692/4019/592/1339; 82/29; 82/58; 82/80; Accumulation; Animals; Biosynthesis; Blood; Blood cells; Blood platelets; Blood Platelets - cytology; Blood Platelets - drug effects; Blood Platelets - metabolism; Cloning; Cytoplasm; Cytoplasm - metabolism; Deletion; Disease Models, Animal; Fibrinolytic Agents - pharmacology; Fibrinolytic Agents - therapeutic use; Humanities and Social Sciences; Humans; Kinases; Life sciences; Lipids; Lymphocytes; Lysophospholipids - metabolism; Male; Medicine; Membrane Proteins - antagonists & inhibitors; Membrane Proteins - genetics; Membrane Proteins - metabolism; Mice; Mice, Knockout; Morphology; multidisciplinary; Physiology; Plasma; Platelet Function Tests; Platelets; Proteins; Roles; Science; Science (multidisciplinary); Sphingolipids; Sphingosine - analogs & derivatives; Sphingosine - metabolism; Sphingosine 1-phosphate; Thrombosis; Venous Thrombosis - blood; Venous Thrombosis - diagnosis; Venous Thrombosis - drug therapy; Venous Thrombosis - pathology